Navigation Links
Short stature -a problem

Very short children are more likely to suffer from behavioural problems, a major study has found. Researchers found that treatment with growth hormone not only boosted growth in children,// but also improved their conduct and relations with other people.

Lead researcher Dr Derick Beens, professor of psychiatry and pediatrics at the University of North Dakota, said: "We believe this work demonstrates that all very short children need to be evaluated thoroughly by psychologists as well as by paediatricians and endocrinologists."

A sample of 345 short children, aged between five and 16, were tested for intelligence, academic achievement, social skills and behaviour problems before starting growth hormone therapy. They were examined again over a three-year period after starting treatment.

Scientists initially found the children suffered a significant level of emotional and psychological problems including anxiety, depression and attention deficit. Despite achieving lower grades at school, the children had near average IQs, and neither IQ nor achievement test scores changed with treatment.

However, after hormone therapy behaviour problems improved. The children were less anxious, attention improved and they were more open. Dr Beens said: "There are several possible explanations for the improvements.

"One is that growth hormone therapy boosts brain chemicals and neurotransmitters that did not work as well as they would have if hormone secretion had been normal." Behaviour problems in short children improved quickly with six months of hormone replacement therapy, Dr Beens said, but that could not be due to growth alone as height increased slowly.


'"/>




Page: 1

Related medicine news :

1. Bad News for Short People
2. Painkillers Do Not Shorten Dying Patients Lives
3. Short stature -a problem
4. Shortage of MMR vaccine
5. Shorter infants have lower incomes in later life
6. Eye Disorders, A Predictor Of A Shorter Lifespan
7. Shorter Radiation Schedules Found To Be More Effective For Patients With Breast Cancer
8. Short term hormone replacement therapy effective
9. New Eye Surgery Gives Hope To Short-Sighted
10. Short Workouts May Not Prevent Weight Gain And Diseases
11. Short Stature Can Be Treated With A New, Non-Growth Hormone In Future
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... 2016 , ... MEDI+SIGN®, a provider of fully-automated patient monitoring ... for Emergency Departments (ED) has been added to their portfolio. Housed in a ... and with a simplified pallet of information available to the patient, the Digital ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West ... January 1, 2017. The name change aligns the entire company with its ... health care quality. , “We are very proud of the achievements associated with ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation , ... and other pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger ... vice president of sales. , Litsinger joined Mirixa in 2008 after serving ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 6.83% during the period ... growth prospects of the global travel vaccines market for 2016-2020. To ... the sales of various vaccines administered to actively immunize meningococcal disease, ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
Breaking Medicine Technology: